Biotest
In January 2022 Dr. Schüttrumpf has been appointed to the Board of Management at Biotest AG. Since 2015 he was responsible for the Research & Development Division, and since 2012 for Global Research at Biotest AG. Before, Dr. Schüttrumpf worked at different academic and non-government organizations in Germany and the US, among those the German Red Cross Blood Donor Service, the Goethe University Frankfurt, the University Hospital of Essen, The Children’s Hospital of Philadelphia, and the University of Pennsylvania. Dr. Schüttrumpf has studied medicine, is specialized in transfusion medicine and haemostaseology, and has a Master of Business Administration from IMD Business School. Dr. Jörg Schüttrumpf was born in 1974.
This person is not in any offices
Biotest
Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.